{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:06:37Z","timestamp":1791414397220,"version":"4.3.3"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.exer.2025.110644","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T06:51:08Z","timestamp":1758178268000},"page":"110644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Diabetic retinopathy as a sentinel of systemic vascular dysfunction: Shared molecular mechanisms with cardiovascular disease"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3768-8659","authenticated-orcid":false,"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1815-5399","authenticated-orcid":false,"given":"Xinwei","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2025.110644_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.dsx.2014.09.011","article-title":"Diabetic retinopathy--biomolecules and multiple pathophysiology","volume":"9","author":"Ahsan","year":"2015","journal-title":"Diabetes Metabol. Syndr."},{"key":"10.1016\/j.exer.2025.110644_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12933-023-01965-7","article-title":"The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction","volume":"22","author":"An","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.exer.2025.110644_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1126055","article-title":"Metabolism-based approaches for autosomal dominant polycystic kidney disease","volume":"10","author":"Bakaj","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.exer.2025.110644_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000579","article-title":"Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus","volume":"8","author":"Bolla","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.exer.2025.110644_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/10600280231224021","article-title":"Reply: tirzepatide, the newest medication for type 2 diabetes: a review of the literature and implications for clinical practice","volume":"58","author":"Bradley","year":"2024","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.exer.2025.110644_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14010072","article-title":"Oxidative stress and cardiovascular complications in type 2 diabetes: from pathophysiology to lifestyle modifications","volume":"14","author":"Caturano","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.exer.2025.110644_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13020-023-00859-w","article-title":"Salvianolic acid B promotes angiogenesis and inhibits cardiomyocyte apoptosis by regulating autophagy in myocardial ischemia","volume":"18","author":"Chen","year":"2023","journal-title":"Chin. Med."},{"key":"10.1016\/j.exer.2025.110644_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2337\/db11-0413","article-title":"Therapeutic effects of PPAR\u03b1 agonists on diabetic retinopathy in type 1 diabetes models","volume":"62","author":"Chen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2025.110644_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14477","article-title":"How inflammation dictates diabetic peripheral neuropathy: an enlightening review","volume":"30","author":"Cheng","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.exer.2025.110644_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/686525","article-title":"Molecular implications of the PPARs in the diabetic eye","volume":"2013","author":"Ciudin","year":"2013","journal-title":"PPAR Res."},{"key":"10.1016\/j.exer.2025.110644_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/629529","article-title":"TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy","volume":"2013","author":"Costagliola","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.exer.2025.110644_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40801-023-00400-3","article-title":"Clinical and demographic characteristics of patients with coexistent hypertension, type 2 diabetes mellitus, and dyslipidemia: a retrospective study from India","volume":"11","author":"Dalal","year":"2024","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.exer.2025.110644_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/2230-8210.152777","article-title":"Association of bilirubin and malondialdehyde levels with retinopathy in type 2 diabetes mellitus","volume":"19","author":"Dave","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.exer.2025.110644_bib14","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s00125-010-1684-1","article-title":"Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009","volume":"53","author":"DeFronzo","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2025.110644_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12933-020-01023-6","article-title":"The relationship between carotid disease and retinopathy in diabetes: a systematic review","volume":"19","author":"Drinkwater","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.exer.2025.110644_bib16","article-title":"Exploring the cardiovascular benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors: expanding horizons beyond diabetes management","volume":"15","author":"Fatima","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.exer.2025.110644_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14261","article-title":"Discovery of genomic and transcriptomic pleiotropy between kidney function and soluble receptor for advanced glycation end products using correlated meta-analyses: the Long Life Family Study","volume":"23","author":"Feitosa","year":"2024","journal-title":"Aging Cell"},{"key":"10.1016\/j.exer.2025.110644_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269087","article-title":"Systematic characterization of the effective constituents and molecular mechanisms of Ardisiae Japonicae Herba using UPLC-Orbitrap Fusion MS and network pharmacology","volume":"17","author":"Feng","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2025.110644_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12123948","article-title":"Quantification of microvascular lesions in the central retinal field: could it predict the severity of diabetic retinopathy?","volume":"12","author":"Fern\u00e1ndez-Carneado","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exer.2025.110644_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8748253","article-title":"Beneficial role of phytochemicals on oxidative stress and age-related diseases","volume":"2019","author":"Forni","year":"2019","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.exer.2025.110644_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0296019","article-title":"Association between red blood cell distribution width\/albumin ratio and all-cause mortality or cardiovascular diseases mortality in patients with diabetic retinopathy: a cohort study","volume":"18","author":"Fu","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2025.110644_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1349069","article-title":"Emerging role of antidiabetic drugs in cardiorenal protection","volume":"15","author":"Fu","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.exer.2025.110644_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/nu15143186","article-title":"Glycyrrhizic acid inhibits high-mobility group box-1 and homocysteine-induced vascular dysfunction","volume":"15","author":"Gadanec","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.exer.2025.110644_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052973","article-title":"New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications","volume":"25","author":"Gallo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110644_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12092150","article-title":"Retinal imaging-based oculomics: artificial intelligence as a tool in the diagnosis of cardiovascular and metabolic diseases","volume":"12","author":"Ghenciu","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.exer.2025.110644_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103332","article-title":"The eye as a non-invasive window to the microcirculation in liver cirrhosis: a prospective pilot study","volume":"9","author":"Gifford","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exer.2025.110644_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/nyas.12044","article-title":"Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials","volume":"1281","author":"Giorgino","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.exer.2025.110644_bib28","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/ATVBAHA.115.305631","article-title":"Elevated plasma levels of MMP-12 are associated with atherosclerotic burden and symptomatic cardiovascular disease in subjects with type 2 diabetes","volume":"35","author":"Goncalves","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.exer.2025.110644_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jch.14649","article-title":"Sex-specific difference in the relationship between body fat percentage and arterial stiffness: results from Fuzhou study","volume":"25","author":"Gong","year":"2023","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.exer.2025.110644_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.603247","article-title":"The impact of antidiabetic therapies on diastolic dysfunction and diabetic cardiomyopathy","volume":"11","author":"Gopal","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.exer.2025.110644_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1200925","article-title":"Association of retinopathy with risk of all-cause and specific-cause mortality in the national health and nutrition examination Survey, 2005 to 2008","volume":"11","author":"Gui","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.exer.2025.110644_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.570553","article-title":"Postprandial glucose Spikes, an Important contributor to cardiovascular disease in diabetes?","volume":"7","author":"Hanssen","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.exer.2025.110644_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/toxics13040236","article-title":"Synergistic toxicity of fine particulate matter and Ozone and their underlying mechanisms","volume":"13","author":"He","year":"2025","journal-title":"Toxics"},{"key":"10.1016\/j.exer.2025.110644_bib34","article-title":"Retinopathy Signs improved prediction and Reclassification of cardiovascular disease risk in diabetes: a prospective cohort study","volume":"7","author":"Ho","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2025.110644_bib35","article-title":"Gene biomarkers related to Th17 cells in macular edema of diabetic retinopathy: Cutting-Edge Comprehensive Bioinformatics analysis and in Vivo Validation","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2025.110644_bib36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12933-023-01816-5","article-title":"Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms","volume":"22","author":"Huang","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.exer.2025.110644_bib37","article-title":"Chronic ocular small vessel disease: an overview of diabetic retinopathy and its relationship with cardiovascular health","volume":"29","author":"Iyer","year":"2023","journal-title":"Am. Heart J."},{"key":"10.1016\/j.exer.2025.110644_bib38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00125-022-05655-z","article-title":"Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies","volume":"65","author":"Jenkins","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2025.110644_bib39","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160589","article-title":"Plasma miR-21 expression: an indicator for the severity of Type 2 diabetes with diabetic retinopathy","volume":"37","author":"Jiang","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.exer.2025.110644_bib40","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1038\/s41598-025-86559-x","article-title":"Diabetic retinopathy further increases risk of cardiovascular disease mortality in a high-risk cohort","volume":"15","author":"Kha","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2025.110644_bib41","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2337\/dc11-0225","article-title":"Diabetic retinopathy in 2011: further insights from new epidemiological studies and clinical trials","volume":"34","author":"Lamoureux","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exer.2025.110644_bib42","article-title":"Association of diabetic retinopathy on all-cause and cause-specific mortality in older adults with diabetes: National Health and Nutrition Examination Survey, 2005-2008","volume":"14","author":"Liang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2025.110644_bib43","article-title":"Tributyrin Intake attenuates angiotensin II-induced Abdominal aortic Aneurysm in LDLR(-\/-) mice","volume":"24","author":"Lin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110644_bib44","article-title":"Diabetes and calcific aortic valve disease: implications of glucose-lowering medication as potential therapy","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.exer.2025.110644_bib45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s40001-023-01431-w","article-title":"Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives","volume":"28","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.exer.2025.110644_bib46","article-title":"The role of aldosterone in the pathogenesis of diabetic retinopathy","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2025.110644_bib47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00018-023-05024-y","article-title":"Glial cell alterations in diabetes-induced neurodegeneration","volume":"81","author":"Llori\u00e1n-Salvador","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.exer.2025.110644_bib48","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1161\/CIRCULATIONAHA.122.059595","article-title":"GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes","volume":"146","author":"Marx","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.exer.2025.110644_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11020284","article-title":"Serum microRNA levels in diabetes mellitus","volume":"11","author":"Mastropasqua","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.exer.2025.110644_bib50","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3389\/fendo.2019.00689","article-title":"Diabetic retinopathy may indicate an increased risk of cardiovascular disease in patients with type 1 diabetes-A Nested Case-control study in Brazil","volume":"10","author":"Melo","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2025.110644_bib51","article-title":"The role of screening, risk factors, and early intervention in preventing diabetes in the obese population: a systematic review","volume":"16","author":"Merwass","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.exer.2025.110644_bib52","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4103\/ijo.IJO_1121_17","article-title":"Biochemical scenario behind initiation of diabetic retinopathy in type 2 diabetes mellitus","volume":"66","author":"Mondal","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110644_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1441924","article-title":"Peptain-1 blocks ischemia\/reperfusion-induced retinal capillary degeneration in mice","volume":"18","author":"Nam","year":"2024","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.exer.2025.110644_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1413441","article-title":"Recent progress of endoplasmic reticulum stress in the mechanism of atherosclerosis","volume":"11","author":"Ni","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.exer.2025.110644_bib55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/IBPC.S9963","article-title":"Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction","volume":"3","author":"Okpechi","year":"2010","journal-title":"Integrated Blood Pres. Control"},{"key":"10.1016\/j.exer.2025.110644_bib56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00592-024-02354-6","article-title":"Comparison of diabetic retinopathy screening between hospital-based multidisciplinary and general practice-based settings: insights from a regional study in Italy","volume":"62","author":"Olivieri","year":"2025","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.exer.2025.110644_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12112589","article-title":"Heart failure: a deficiency of energy-A path yet to discover and walk","volume":"12","author":"Paraskevaidis","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.exer.2025.110644_bib58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12933-024-02417-6","article-title":"Cardiometabolic benefits of fenofibrate in heart failure related to obesity and diabetes","volume":"23","author":"Park","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.exer.2025.110644_bib59","article-title":"Critical role of the coronary microvasculature in heart disease: from pathologic driving force to \"innocent\" bystander","volume":"22","author":"Prakash","year":"2022","journal-title":"Am. Heart J."},{"key":"10.1016\/j.exer.2025.110644_bib60","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/joco.joco_70_21","article-title":"Association of use of statins with progression of diabetic retinopathy at a tertiary care hospital in Southern India","volume":"34","author":"Priyadarshini","year":"2022","journal-title":"J Curr Ophthalmol"},{"key":"10.1016\/j.exer.2025.110644_bib61","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1111\/dom.16332","article-title":"Use of adjunctive glycaemic agents with vascular protective properties in individuals with type 1 diabetes: potential benefits and risks","volume":"27","author":"Rajab","year":"2025","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.exer.2025.110644_bib62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11883-025-01279-x","article-title":"Inflammation-driven plaque erosion in atherosclerosis: a focus on complement system pathways","volume":"27","author":"Ramoni","year":"2025","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.exer.2025.110644_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111234","article-title":"Role of peroxisome proliferator-activated receptors \u03b1 and \u03b3 in mediating the beneficial effects of \u03b2-caryophyllene in a rat model of fragile X syndrome","volume":"136","author":"Rava","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.exer.2025.110644_bib64","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12933-017-0531-9","article-title":"Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells","volume":"16","author":"Ren","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.exer.2025.110644_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12040890","article-title":"Associations between skin autofluorescence levels with cardiovascular risk and diabetes complications in patients with type 2 diabetes","volume":"12","author":"Reurean-Pintilei","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.exer.2025.110644_bib66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12872-024-04374-0","article-title":"Early prediction of Cardio Vascular Disease (CVD) from diabetic retinopathy using improvised deep belief network (I-DBN) with optimum feature selection technique","volume":"25","author":"Revathi","year":"2025","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.exer.2025.110644_bib67","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12933-022-01675-6","article-title":"Synergistic effect of chronic kidney disease, neuropathy, and retinopathy on all-cause mortality in type 1 and type 2 diabetes: a 21-year longitudinal study","volume":"21","author":"Sacchetta","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.exer.2025.110644_bib68","doi-asserted-by":"crossref","DOI":"10.1007\/s00417-025-06769-x","article-title":"Coronary artery and retinal vascularization by optical coherence tomography angiography: are eyes the window to the heart?","author":"Sakuno","year":"2025","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110644_bib69","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1758-5996-6-57","article-title":"Angiotensin II receptor blocker telmisartan attenuates aortic stiffening and remodelling in STZ-diabetic rats","volume":"6","author":"Salum","year":"2014","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.exer.2025.110644_bib70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4093\/dmj.2022.0325","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus","volume":"47","author":"Sasako","year":"2023","journal-title":"Diabetes Metab. J"},{"key":"10.1016\/j.exer.2025.110644_bib71","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12933-024-02500-y","article-title":"Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives","volume":"23","author":"Sawami","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.exer.2025.110644_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cells14050376","article-title":"Diabetic Retinopathy (DR): mechanisms, current therapies, and emerging strategies","volume":"14","author":"Seo","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.exer.2025.110644_bib73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13578-024-01269-7","article-title":"Microvascular destabilization and intricated network of the cytokines in diabetic retinopathy: from the perspective of cellular and molecular components","volume":"14","author":"Sheng","year":"2024","journal-title":"Cell Biosci."},{"key":"10.1016\/j.exer.2025.110644_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.833355","article-title":"Type 2 diabetes contributes to altered adaptive immune responses and vascular inflammation in patients with SARS-CoV-2 infection","volume":"13","author":"Singh","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2025.110644_bib75","article-title":"Emerging therapeutic strategies in cardiovascular diseases","volume":"16","author":"Singh","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.exer.2025.110644_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25105221","article-title":"Lemon flavonoid extract eriomin improves pro\/antioxidant status and interferes with cholesterol metabolism without affecting serum Cholesterol levels in aged rats","volume":"25","author":"\u0160o\u0161i\u0107-Jurjevi\u0107","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110644_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1270145","article-title":"The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern","volume":"14","author":"Sun","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2025.110644_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.757088","article-title":"Plasma Metabolomics reveals metabolic profiling for diabetic retinopathy and disease progression","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2025.110644_bib79","article-title":"Associations of antidiabetic drugs with diabetic retinopathy in people with type 2 diabetes: an umbrella review and meta-analysis","volume":"14","author":"Tan","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2025.110644_bib80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40662-024-00384-3","article-title":"Prognostic potentials of AI in ophthalmology: systemic disease forecasting via retinal imaging","volume":"11","author":"Tan","year":"2024","journal-title":"Eye Vis (Lond)"},{"key":"10.1016\/j.exer.2025.110644_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13050594","article-title":"Diabetic retinopathy: new treatment approaches targeting redox and immune mechanisms","volume":"13","author":"Tang","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.exer.2025.110644_bib82","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jamaophthalmol.2024.5219","article-title":"Empagliflozin and the risk of retinopathy in patients with type 2 diabetes","volume":"143","author":"Tesfaye","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.exer.2025.110644_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13123561","article-title":"Evaluation of cardiovascular disease risk in patients with type 2 diabetes mellitus using clinical laboratory markers","volume":"13","author":"Ulambayar","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exer.2025.110644_bib84","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1177\/11206721211064024","article-title":"The relationship between carotid intima-media thickness and microvascular changes in retinal zones and optic disc in patients with type 1 diabetes mellitus","volume":"32","author":"Ulutas","year":"2022","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110644_bib85","article-title":"A narrative review of the advances in screening methods for diabetic retinopathy: enhancing early detection and vision preservation","volume":"16","author":"Upadhyay","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.exer.2025.110644_bib86","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2147\/IJNRD.S268811","article-title":"SGLT2 inhibitors: emerging roles in the protection against cardiovascular and kidney disease Among diabetic patients","volume":"13","author":"Vasquez-Rios","year":"2020","journal-title":"Int. J. Nephrol. Renovascular Dis."},{"key":"10.1016\/j.exer.2025.110644_bib87","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S2213-8587(14)70256-6","article-title":"Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis","volume":"3","author":"Wang","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.exer.2025.110644_bib88","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3448618","article-title":"The influence of different types of diabetes on vascular complications","volume":"2022","author":"Wei","year":"2022","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.exer.2025.110644_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.963615","article-title":"The pathophysiological mechanisms underlying diabetic retinopathy","volume":"10","author":"Wei","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.exer.2025.110644_bib90","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12933-025-02608-9","article-title":"Glucagon like peptide-1 (GLP-1) agonists and cardiometabolic protection: historical development and future challenges","volume":"24","author":"Westermeier","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.exer.2025.110644_bib91","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1139\/cjpp-2022-0065","article-title":"Cardiodiabetology: newer pharmacologic strategies for reducing cardiovascular disease risks","volume":"100","author":"Wong","year":"2022","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.exer.2025.110644_bib92","article-title":"Mitochondrial-derived peptides in diabetes and its complications","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2025.110644_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1260592","article-title":"Effects of inflammation on myopia: evidence and potential mechanisms","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2025.110644_bib94","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12872-020-01763-z","article-title":"Diabetic retinopathy predicts cardiovascular mortality in diabetes: a meta-analysis","volume":"20","author":"Xu","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.exer.2025.110644_bib95","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13287-022-02791-6","article-title":"Human umbilical cord-derived mesenchymal stem cells alleviate insulin resistance in diet-induced obese mice via an interaction with splenocytes","volume":"13","author":"Xue","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.exer.2025.110644_bib96","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13098-024-01322-y","article-title":"miR-449a disturbs atherosclerotic plaque stability in streptozotocin and high-fat diet-induced diabetic mice by targeting CEACAM1","volume":"16","author":"Yu","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.exer.2025.110644_bib97","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.2147\/DMSO.S438111","article-title":"Diabetic retinopathy and cardiovascular disease: a literature review","volume":"16","author":"Yu","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.exer.2025.110644_bib98","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.ATV.0000204327.96431.9a","article-title":"Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence","volume":"26","author":"Zambon","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.exer.2025.110644_bib99","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/jdi.14382","article-title":"Association between early-stage diabetic nephropathy and the delayed monophasic glucose peak during oral glucose tolerance test in type 2 diabetes mellitus","volume":"16","author":"Zhang","year":"2025","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.exer.2025.110644_bib100","article-title":"Therapeutic potential of GLP-1 receptor agonists in diabetes and cardiovascular disease: mechanisms and clinical implications","author":"Zhang","year":"2025","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.exer.2025.110644_bib101","article-title":"Identification of biomarkers associated with immune scores in diabetic retinopathy","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2025.110644_bib102","article-title":"Association of insulin resistance-related indicators with cardiovascular disease in Chinese people with different glycemic states","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Endocrinol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525004166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525004166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:03:34Z","timestamp":1780722214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483525004166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":102,"alternative-id":["S0014483525004166"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2025.110644","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic retinopathy as a sentinel of systemic vascular dysfunction: Shared molecular mechanisms with cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2025.110644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110644"}}